Levantamento do fitoplancton no açude Manga Nova, Petrolina, PE.

a. Assim,o objetivodo trabalhofoi monitoraras característicasda qualidadeda água, sedimento e análise morfométricado açude, para a otimização do cultivo extensivo

A fluorescent-labeled microcystin-LR terbium cryptate

Um novo composto fluorescente de microcistina-LR marcado com criptato de térbio foi obtido pela conjugação inicial da microcistina-LR com aminoetanotiol, seguido pela reação com o grupo éster do criptato de térbio. A formação do produto foi acompanhada por cromatografia líquida de alta eficiência (CLAE) em 238 nm e 310 nm. A presença de microcistina-LR na molécula marcada foi confirmada através de ensaio com enzima ligada a imunoabsorvente (ELISA) e por reação protéica com ácido bicincônico. O espectro de luminescência do criptato e da molécula conjugada também foram confirmados.A new fluorescent labeled compound of microcystin-LR with terbium cryptate was obtained by initial conjugation of microcystins-LR with aminoethanethiol followed by the reaction with the ester group of terbium cryptate. The product formation was followed by high performance liquid chromatography (HPLC) at 238 nm and 310 nm. The presence of microcystin-LR in the labeled molecule was confirmed by enzyme linked immunosorbent assay ELISA and by protein reaction with bicinhonic acid. Luminescence spectra of cryptate and the conjugated molecule were carried through as well

Actividad antifúngica de extractos de plantas contra cepas de Microsporum canis y Candida spp.

Con el objetivo de encontrar compuestos fitoterapéuticos para tratar las infecciones por hongos de los animales, plantas que se encuentran comúnmente en el noreste de Brasil se evaluaron in vitro frente a cepas de Microsporum canis y Candida spp. aisladas de perros y gatos. Los extractos etanólicos de hojas de Momordica charantia, Calotropis procera, Peschiera affinis y Piper tuberculatum y la decocción de Mangifera índica fueron evaluados inicialmente por el método de difusión en pocillos de agar. Cuatro extractos indujeron zonas de inhibición del crecimiento contra M. canis: P. tuberculatum (20 mm), M. índica (14 mm), M. charantia (13 mm) y P. affinis (11 mm). Ninguno de ellos fue activo contra Candida spp. Se realizaron pruebas de microdilución en caldo para las cepas de M. canis (n = 5), para encontrar la concentración mínima inhibitoria (CIM) y la concentración fungicida mínima (CFM). Las medias geométricas de los valores de CIM fueron 590, 370, 350, 170 mg/ml, y para los valores de CFM fueron 1.190, 750, 700, 340 mg/ml de M. charantia, P. affinis, P. tuberculatum y M. indica, respectivamente. Por lo tanto, los extractos de M. charantia, P. affinis, P. tuberculatum y M. indica son buenos candidatos para la producción de fitoterápicos antifúngicos ya que estos extractos demostraron una buena actividad contra M. canis

Evidence for the h_b(1P) meson in the decay Upsilon(3S) --> pi0 h_b(1P)

Using a sample of 122 million Upsilon(3S) events recorded with the BaBar detector at the PEP-II asymmetric-energy e+e- collider at SLAC, we search for the $h_b(1P)$ spin-singlet partner of the P-wave chi_{bJ}(1P) states in the sequential decay Upsilon(3S) --> pi0 h_b(1P), h_b(1P) --> gamma eta_b(1S). We observe an excess of events above background in the distribution of the recoil mass against the pi0 at mass 9902 +/- 4(stat.) +/- 2(syst.) MeV/c^2. The width of the observed signal is consistent with experimental resolution, and its significance is 3.1sigma, including systematic uncertainties. We obtain the value (4.3 +/- 1.1(stat.) +/- 0.9(syst.)) x 10^{-4} for the product branching fraction BF(Upsilon(3S)-->pi0 h_b) x BF(h_b-->gamma eta_b).Comment: 8 pages, 4 postscript figures, submitted to Phys. Rev. D (Rapid Communications

Performance of the CMS Cathode Strip Chambers with Cosmic Rays

The Cathode Strip Chambers (CSCs) constitute the primary muon tracking device in the CMS endcaps. Their performance has been evaluated using data taken during a cosmic ray run in fall 2008. Measured noise levels are low, with the number of noisy channels well below 1%. Coordinate resolution was measured for all types of chambers, and fall in the range 47 microns to 243 microns. The efficiencies for local charged track triggers, for hit and for segments reconstruction were measured, and are above 99%. The timing resolution per layer is approximately 5 ns

Using a Non-Image-Based Medium-Throughput Assay for Screening Compounds Targeting N-myristoylation in Intracellular Leishmania Amastigotes

We have refined a medium-throughput assay to screen hit compounds for activity against N-myristoylation in intracellular amastigotes of Leishmania donovani. Using clinically-relevant stages of wild type parasites and an Alamar blue-based detection method, parasite survival following drug treatment of infected macrophages is monitored after macrophage lysis and transformation of freed amastigotes into replicative extracellular promastigotes. The latter transformation step is essential to amplify the signal for determination of parasite burden, a factor dependent on equivalent proliferation rate between samples. Validation of the assay has been achieved using the anti-leishmanial gold standard drugs, amphotericin B and miltefosine, with EC50 values correlating well with published values. This assay has been used, in parallel with enzyme activity data and direct assay on isolated extracellular amastigotes, to test lead-like and hit-like inhibitors of Leishmania Nmyristoyl transferase (NMT). These were derived both from validated in vivo inhibitors of Trypanosoma brucei NMT and a recent high-throughput screen against L. donovani NMT. Despite being a potent inhibitor of L. donovani NMT, the activity of the lead T. brucei NMT inhibitor (DDD85646) against L. donovani amastigotes is relatively poor. Encouragingly, analogues of DDD85646 show improved translation of enzyme to cellular activity. In testing the high-throughput L. donovani hits, we observed macrophage cytotoxicity with compounds from two of the four NMT-selective series identified, while all four series displayed low enzyme to cellular translation, also seen here with the T. brucei NMT inhibitors. Improvements in potency and physicochemical properties will be required to deliver attractive lead-like Leishmania NMT inhibitors

Gut microbiome signature and nasal lavage inflammatory markers in young people with asthma

BACKGROUND: Asthma is a complex disease and a severe global public health problem resulting from interactions between genetic background and environmental exposures. It has been suggested that gut microbiota may be related to asthma development; however, such relationships needs further investigation. OBJECTIVE: This study aimed to characterize the gut microbiota as well as the nasal lavage cytokine profile of asthmatic and nonasthmatic individuals. METHODS: Stool and nasal lavage samples were collected from 29 children and adolescents with type 2 asthma and 28 children without asthma in Brazil. Amplicon sequencing of the stool bacterial V4 region of the 16S rRNA gene was performed using Illumina MiSeq. Microbiota analysis was performed by QIIME 2 and PICRUSt2. Type 2 asthma phenotype was characterized by high sputum eosinophil counts and positive skin prick tests for house dust mite, cockroach, and/or cat or dog dander. The nasal immune marker profile was assessed using a customized multiplex panel. RESULTS: Stool microbiota differed significantly between asthmatic and nonasthmatic participants (P = .001). Bacteroides was more abundant in participants with asthma (P < .05), while Prevotella was more abundant in nonasthmatic individuals (P < .05). In people with asthma, the relative abundance of Bacteroides correlated with IL-4 concentration in nasal lavage samples. Inference of microbiota functional capacity identified differential fatty acid biosynthesis in asthmatic compared to nonasthmatic subjects. CONCLUSION: The stool microbiota differed between asthmatic and nonasthmatic young people in Brazil. Asthma was associated with higher Bacteroides levels, which correlated with nasal IL-4 concentration

Aligning the CMS Muon Chambers with the Muon Alignment System during an Extended Cosmic Ray Run

Peer reviewe